Fred Alger Management’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-15,872
Closed -$3.34M 480
2023
Q2
$3.34M Sell
15,872
-221,629
-93% -$44.1M 0.02% 288
2023
Q1
$47.9M Buy
+237,501
New +$53.8M 0.26% 113
2022
Q2
Sell
-119
Closed -$34K 514
2022
Q1
$34K Sell
119
-107
-47% -$33K ﹤0.01% 469
2021
Q4
$85K Buy
226
+50
+28% +$19.4K ﹤0.01% 448
2021
Q3
$73K Buy
176
+19
+12% +$7.89K ﹤0.01% 447
2021
Q2
$58K Buy
157
+69
+78% +$23K ﹤0.01% 464
2021
Q1
$26K Buy
+88
New +$24.5K ﹤0.01% 450
2017
Q3
Sell
-3,500
Closed -$354K 517
2017
Q2
$354K Buy
+3,500
New +$322K ﹤0.01% 376
2016
Q4
Sell
-33,243
Closed -$2.77M 492
2016
Q3
$2.77M Sell
33,243
-16,815
-34% -$1.41M 0.01% 243
2016
Q2
$4.13M Buy
50,058
+36,608
+272% +$3.02M 0.02% 221
2016
Q1
$1.02M Buy
+13,450
New +$996K 0.01% 373
2014
Q2
Sell
-919,970
Closed -$55.5M 634
2014
Q1
$55.5M Sell
919,970
-12,046
-1% -$702K 0.28% 96
2013
Q4
$49.4M Buy
932,016
+38,972
+4% +$1.96M 0.25% 104
2013
Q3
$41.3M Sell
893,044
-130,601
-13% -$5.99M 0.23% 119
2013
Q2
$42M Buy
+1,023,645
New +$43.9M 0.25% 111

Other funds holding CRL

Fred Alger Management's CRL Position: Q3 2023 in Review

Fred Alger Management sold out of Charles River Laboratories (CRL) in Q3 2023, closing a stake of 15,872 shares — an estimated $3.34M sold.

Fred Alger Management first reported a position in CRL in Q2 2013 and held it in 15 quarters. The position peaked at $55.5M in Q1 2014. 621 funds tracked by Wall St. Rank hold CRL as of Q3 2023.

  • Fred Alger Management reported no remaining Charles River Laboratories position as of Q3 2023 after selling out during the quarter.
  • Fred Alger Management sold 15,872 Charles River Laboratories shares in Q3 2023, an estimated $3.34M.
  • Fred Alger Management first reported a position in Charles River Laboratories in Q2 2013 and held it in 15 quarters.
  • Fred Alger Management's Charles River Laboratories position peaked at $55.5M in Q1 2014.
  • 621 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2023.

Based on Fred Alger Management's 13F filing for Q3 2023, filed 14 Nov 2023.